Reduction in preference for saccharin by repeated unpredictable stress in mice and its prevention by imipramine

被引:74
作者
Harkin, A [1 ]
Houlihan, DD [1 ]
Kelly, JP [1 ]
机构
[1] Natl Univ Ireland Univ Coll Galway, Dept Pharmacol, Galway, Ireland
关键词
CD-1; mouse; chronic mild stress; imipramine; saccharin;
D O I
10.1177/026988110201600201
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The present study set out to establish the chronic mild stress (CMS) animal model of depression in male CD-1 mice, a commonly used mouse strain. Mice were exposed to a series of mild stressors (e.g. soiled bedding, paired housing, cage tilt, white-noise)presented in a continuous unpredictable fashion. Intermittently, CMS was discontinued and the mice were presented with both water and a palatable saccharin solution (0.1% w/v) in a two-bottle choice test overnight (15 h). Repeated exposure of these mice to the stressors led to a reduction in preference for the saccharin solution. This change in preference was attributed to an increase in the consumption of water rather than a decrease in the consumption of saccharin solution. Over time and with extensive testing, CMS no longer affected performance in the two-bottle saccharin preference test. Treatment with the tricyclic antidepressant imipramine (20 mg/kg i.p., once daily) had a varied effect on the CMS-induced change in preference for saccharin, dependent on the timing of initiation of imipramine treatment. In the first instance, following 5 weeks of CMS where a reduction in saccharin preference was established, treatment with imipramine for a further 5 weeks maintained the stress-induced deficit in saccharin preference. However, using a different approach, pre-treatment with imipramine once daily for 2 weeks, prior to onset of CMS, and co-treatment thereafter, attenuated CMS-induced changes in saccharin preference. Finally, when imipramine treatment was scheduled to begin with the CMS procedure, imipramine failed to prevent the CMS-induced reductions in saccharin preference. Changes in behaviour observed after exposure to CMS may be linked to a stress-induced deterioration of the sensitivity of the mice to a rewarding stimulus. Treatment with imipramine can reduce these behavioural changes but is only effective when given repeatedly prior to onset of CMS.
引用
收藏
页码:115 / 123
页数:9
相关论文
共 33 条
[1]   EFFECTS OF CHRONIC MILD STRESS ON SERUM COMPLEMENT ACTIVITY, SACCHARIN PREFERENCE, AND CORTICOSTERONE LEVELS IN FLINDERS LINES OF RATS [J].
AYENSU, WK ;
PUCILOWSKI, O ;
MASON, GA ;
OVERSTREET, DH ;
REZVANI, AH ;
JANOWSKY, DS .
PHYSIOLOGY & BEHAVIOR, 1995, 57 (01) :165-169
[2]   Effects of chronic mild stress (CMS) and imipramine administration, on spleen mononuclear cell proliferative response, serum corticosterone level and brain norepinephrine content in male mice [J].
Azpiroz, A ;
Fano, E ;
Garmendia, L ;
Arregi, A ;
Cacho, R ;
Beitia, G ;
Brain, PF .
PSYCHONEUROENDOCRINOLOGY, 1999, 24 (03) :345-361
[3]   WHAT DOES INDIVIDUAL HOUSING MEAN TO A MOUSE [J].
BRAIN, P .
LIFE SCIENCES, 1975, 16 (02) :187-200
[4]   What is mild in mild stress? [J].
Cabib, S .
PSYCHOPHARMACOLOGY, 1997, 134 (04) :344-346
[5]   STEREOSPECIFIC REVERSAL OF STRESS-INDUCED ANHEDONIA BY MIANSERIN AND ITS (+)-ENANTIOMER [J].
CHEETA, S ;
BROEKKAMP, C ;
WILLNER, P .
PSYCHOPHARMACOLOGY, 1994, 116 (04) :523-528
[6]   Anti-anhedonic actions of the novel serotonergic agent flibanserin, a potential rapidly-acting antidepressant [J].
D'Aquila, P ;
Monleon, S ;
Borsini, F ;
Brain, P ;
Willner, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 340 (2-3) :121-132
[7]   Diurnal variation in the effect of chronic mild stress on sucrose intake and preference [J].
DAquila, PS ;
Newton, J ;
Willner, P .
PHYSIOLOGY & BEHAVIOR, 1997, 62 (02) :421-426
[8]   Chronic mild stress and sucrose consumption: Validity as a model of depression [J].
Forbes, NF ;
Stewart, CA ;
MAtthews, K ;
Reid, IC .
PHYSIOLOGY & BEHAVIOR, 1996, 60 (06) :1481-1484
[9]   Revised CMS model [J].
Hagan, JJ ;
Hatcher, JP .
PSYCHOPHARMACOLOGY, 1997, 134 (04) :354-356
[10]   ANIMAL-MODEL OF DEPRESSION - PHARMACOLOGICAL SENSITIVITY OF A HEDONIC DEFICIT [J].
KATZ, RJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1982, 16 (06) :965-968